Forholdet mellem in vitro- følsomheden af HIV over for lamivudin og det kliniske respons af behandling hvor lamivudin er indeholdt undersøges forsat.
The relationship between in vitro susceptibility of HIV to lamivudine and clinical response to lamivudine-containing therapy remains under investigation.